Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Intercos S.p.A. ( (IT:ICOS) ) just unveiled an update.
Intercos S.p.A. has executed a bonus share capital increase linked to its 2023-2025 Performance Shares Plan for employees, issuing 30,544 new ordinary shares without nominal value. As a result, the fully paid-in share capital rose slightly to €11,317,100.75, with the total number of shares increasing to 96,394,564 and voting rights to 127,394,165, while the structure of ordinary shares with increased voting rights remains unchanged.
The capital change, formally registered with the Milan, Monza, Brianza and Lodi Companies Register on 6 March 2026, reflects Intercos’s ongoing use of equity-based incentives to align employees with shareholder interests. The updated Articles of Association, reflecting the new capital structure, will be made available to investors and stakeholders on the company’s website, through the authorized storage mechanism and at the registered office, enhancing transparency around the group’s governance and capital composition.
The most recent analyst rating on (IT:ICOS) stock is a Hold with a EUR13.00 price target. To see the full list of analyst forecasts on Intercos S.p.A. stock, see the IT:ICOS Stock Forecast page.
More about Intercos S.p.A.
Intercos S.p.A. is a leading global business-to-business provider in the cosmetics and broader beauty market, specializing in the creation, production and marketing of make-up, skincare, and hair and body care products. Founded in 1972, the group serves major international and emerging beauty brands and retailers, supported by over 6,000 employees, 12 research centers, 15 production plants and 16 commercial offices across three continents.
Average Trading Volume: 119,314
Technical Sentiment Signal: Hold
Current Market Cap: €1.19B
Learn more about ICOS stock on TipRanks’ Stock Analysis page.

